Defined Bioscience is a biotechnology startup focused on providing ingredients for cell culture. Their mission is to revolutionize the process of growing cells for stem cell R&D and cultured meat production. The company aims to make a positive impact by reducing animal dependency for lab reagents and food production. Defined Bio prioritizes improving cell growth quality, reducing costs, and enhancing user-friendliness in their journey. They recognize the significance of fundamental ingredients such as growth factors, proteins, buffers, and growth/differentiation analysis in developing defined, animal-free growth media.
Founded in 2020, Defined Bioscience has developed innovative reagents by leveraging optimized recipes from leaders in the field. Their focus on exceptional reagents, media, and protocols is anticipated to significantly enhance the quality and cost-efficiency of growing stem cells and iPSC derived cells. As a venture capital professional, it's worth monitoring the progress and potential of Defined Bioscience in the ever-evolving biotechnology industry, especially given their unique position at the intersection of cell culture, stem cell research, and sustainable food production.
There is no investment information
No recent news or press coverage available for Defined Bioscience.